Karimi F, Arya A. SGLT2 Inhibitor-Induced Ketonemia and Its Related Metabolic and Anti-Inflammatory Impacts in Adult Patients with Type 2 Diabetes: SGLT2 inhibitor-induced ketonemia in type 2 diabetes. Iran J Pharm Sci [Internet]. 2023 Apr. 1 [cited 2026 Jun. 30];19(2):176-87. Available from: https://theses.sbmu.ac.ir/index.php/ijps/article/view/42072